TrialNet

Arif, S., Gomez-Tourino, I., Kamra, Y., Pujol-Autonell, I., Hanton, E., Tree, T., … Peakman, M. (2020). GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. Diabetologia, 63(6), 1186-1198. https://doi.org/10.1007/s00125-020-05130-7 (Original work published 2020)